72
ผศ.นพ.สุรพงษ์ หล่อสมฤดี TIVA Center Division of Cardiothoracic and Vascular Anesthesia Division of Transplantation Anesthesia Chiang Mai University Hospital Why do we need NMBAs for RSI

Surapong rsi 2009

  • Upload
    taem

  • View
    1.050

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Surapong rsi 2009

ผศ.นพ.สรุพงษ์ หล่อสมฤดีTIVA Center

Division of Cardiothoracic and Vascular Anesthesia

Division of Transplantation Anesthesia

Chiang Mai University Hospital

Why do we need NMBAs

for RSI

Page 2: Surapong rsi 2009
Page 3: Surapong rsi 2009
Page 4: Surapong rsi 2009

Lorsomradee, et al: J Cardiothorac Vasc Anesth. 2007

Oct;21(5):636-43.

Hemodynamic Effects

Painful stimulus

Page 5: Surapong rsi 2009

Lorsomradee, et al: Anaesthesia. 2007

Oct;62(10):979-83.

Vasoconstrictor

Phenylephrine

Page 6: Surapong rsi 2009

Reversible myocardial ischemia

Stunning

A transient period of

depressed myocardial function

that follows a period of ischemia,

not sufficient to result in cell death

Page 7: Surapong rsi 2009

Cardioprotection: Myocardial oxygen balance

O2 supply

O2 demand<

ischemia

supply demand

Heart rate

contractility

afterload

CBF: normal region

CBF: ischemic region

subendocardium

Page 8: Surapong rsi 2009

Rapid Sequence Intubation (RSI)

• The induction of a state

of unconsciousness with

complete neuromuscular

paralysis to achieve

intubation without

interposed mechanical

ventilation in efforts to

facilitate the procedure

and minimize risks of

gastric aspiration

Page 9: Surapong rsi 2009

Chiang Mai Medical Journal 2008;48(3suppl)

Page 10: Surapong rsi 2009

Rapid Sequence

Intubation experience in

Emergency DepartmentMaharaj Nakorn Chiang Mai

นพ.บวร วิทยช ำนำญกุลEmergency Medicine

Chiang Mai University Hospital

Page 11: Surapong rsi 2009

History

• Awake intubation

• Diazepam ???

• Midazolam

Page 12: Surapong rsi 2009

• Establish Training EM in 2548

• Workshop RSI in January 2551

• RSI in ER October 2551

• Etomidate + Succinylcholine

• Etomidate + Rocuronium

• Propofol

Page 13: Surapong rsi 2009

28

20

3

12

14

0

5

10

15

20

25

30

1 attempt 2 attempt 3 attempt

RSI 32 non RSI 36

Page 14: Surapong rsi 2009

2

3

2

4

1

2 2

6

0

4

0

2

0

1

2

3

4

5

6

Hypotension Desaturation Vomit prolonged

intubation

Oral trauma Esophageal

intubation

RSI non RSI

Page 15: Surapong rsi 2009

Now

• More than 150 experience of RSI

• Staff attending 24 hr

• ER staff in morning shift and

some noon – night shift

Page 16: Surapong rsi 2009

Quality Control

• Resident 2 : training, coaching, direct

observe

• Difficult airway cart

• No serious adverse event

Page 17: Surapong rsi 2009

Rapid Sequence Intubation

“6 P’s”

• Preparation: T-10”

–Positioning

• Preoxygenation: T-5”

• Premedication: T-3”

• Paralysis:T-0

• Placement of tube: T+45

• Post management: T+2”

Page 18: Surapong rsi 2009

Preparation

• Evaluate

– LEMON

• Equipment Check

• Positioning

• Drug Selection

• IV’s, monitor, oximetry

• Ancillary Staff

• Anticipate alternative airway maneuver

Page 19: Surapong rsi 2009

• LEMON

–L-look

–E-evaluate the 3-3-2 rule

–M-Mallampati

–O-Obstruction

–N-Neck mobility

Page 20: Surapong rsi 2009

Preoxygenation

• 100% O2 for 5 minutes of 5 vital

capacity breaths can theoretically

permit 3-5 minutes of apnea

before desaturation to less than

90% occurs

Page 21: Surapong rsi 2009

Troubleshoot• Hypotension after procedure

• > 1 attempt

– Non experience

– Position

Page 22: Surapong rsi 2009

Prepare : sniff position

Page 23: Surapong rsi 2009

Prepare : sniff position

Page 24: Surapong rsi 2009

Troubleshoot• Hypotension after procedure

• > 1 attempt

– Non experience

– Position

– Not wait til onset of drugs

• Myoclonus 1 time

• Drug preparation time

Page 25: Surapong rsi 2009

Tip & Trick in RSI

Page 26: Surapong rsi 2009

Airway Assessment

Page 27: Surapong rsi 2009
Page 28: Surapong rsi 2009
Page 29: Surapong rsi 2009
Page 30: Surapong rsi 2009
Page 32: Surapong rsi 2009
Page 33: Surapong rsi 2009
Page 34: Surapong rsi 2009
Page 35: Surapong rsi 2009

Muscle Relaxation

Page 36: Surapong rsi 2009
Page 37: Surapong rsi 2009
Page 38: Surapong rsi 2009

Succinylcholine

Rapid onset

Profound depth of NMB

Short duration of action

Page 39: Surapong rsi 2009

Succinylcholine’s weaknesses

Cardiovascular effects

sinus bradycardia

nodal rhythm

ventricular dysrhythm

Increase IOcP

Increase IGP

Increase ICP

Page 40: Surapong rsi 2009

Succinylcholine’s weaknesses• Myalgia

• Masseter spasm

• Fasciculations

• Anaphylaxis

• Abnormal plasma cholinesterase

• Hyperkalemia

Page 41: Surapong rsi 2009

Overview NMBAs

Arguments against Succinycholine

• Used just out of convenience

• Many contraindications in particular in certain

patient populations

• FDA Warning box for pediatrics

• Perceived advantage of fast spontaneous

breathing in “can’t intubate, can’t ventillate” is

not as fast in reality

• Severity of its side effects may increase costs of

prolonged hospital stay and treatment

Page 42: Surapong rsi 2009

Contraindications• MH

• Burn

• UMNL

• Severe muscle trauma

• Disuse atrophy

Page 43: Surapong rsi 2009

Is Suxamethonium Really Safe ?

Morbidity

Fasciculation

C-spine

Page 44: Surapong rsi 2009

Comparative Intubating Doses and Time to Intubation of NDMRs

Page 45: Surapong rsi 2009

Effects of Rocuronium on Heart Rate

Time (minutes)

100

90

80

70

60

50

40

0.0 1.0 2.0 3.0 4.0 5.0 6.0

He

art

Ra

te (

be

ats

/min

)

Levy et al. Anesth Analg 1994;78,318-321.

600 mcg/kg

900 mcg/kg

1200 mcg/kg

Page 46: Surapong rsi 2009

Effects of Rocuronium on Mean Arterial Pressure

Time (minutes)

100

90

80

70

60

50

0.0 1.0 2.0 3.0 4.0 5.0 6.0

Me

an

Art

eria

l P

ressu

re (

mm

Hg

) 600 mcg/kg

900 mcg/kg

1200 mcg/kg

Levy et al. Anesth Analg 1994;78,318-321.

Page 47: Surapong rsi 2009

Effects of Rocuronium on Histamine Release

Time (minutes)

0.0 1.0 2.0 3.0 4.0 5.0

Pla

sm

a H

ista

min

e (

ng

/ml)

Levy et al. Anesth Analg 1994;78,318-321.

600 mcg/kg

900 mcg/kg

1200 mcg/kg

3.0

2.5

2.0

1.5

1.0

0.5

0.0

Page 48: Surapong rsi 2009

ROCURONIUM:

TRACHEAL INTUBATION

• Median time to 80% block with

0.6 mg/kg is 60 seconds (0.4-

6.0 minutes)

• Median onset time with 0.6

mg/kg is 1.8 minutes (0.6-13

minutes)

Page 49: Surapong rsi 2009

LOW DOSE

PHARMACODYNAMICS:

CLINICAL PARAMETERS

Rocuronium br Dose: 0.45 mg/kg (n = 14)

Mean maximum blockade 96 ± 5%

Mean time to 80% blockade 117 ± 24

seconds

Mean time to maximum blockade 214 ± 25

seconds

Mean time to completion of intubation 159 ± 25

seconds

Page 50: Surapong rsi 2009

ROCURONIUM BROMIDE:

TRACHEAL INTUBATION

• Median time to 80% blockade with 0.9 mg/kg is 66 seconds (0.3-3.8 minutes)

• Median onset time with 0.9 mg/kg is 84 seconds (0.8-6.2 minutes)

• Median time to 80% blockade with 1.2 mg/kg is 42 seconds (0.4-1.7 minutes)

• Median onset time with 1.2 mg/kg is 60 seconds (0.6-4.7 minutes)

Page 51: Surapong rsi 2009

Rocuronium versus succinylcholine

for rapid sequence induction intubation (Review)

Succinylcholine created superior intubation

conditions to rocuronium when comparing both

excellent and clinically acceptable intubating conditions.

This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library

2008, Issue 3http://www.thecochranelibrary.com

Rocuronium versus

Page 52: Surapong rsi 2009

Rocuronium bromide 0.6 mg/kg

spontaneous recovery

Page 53: Surapong rsi 2009

Rocuronium bromide 0.6 mg/kg

reversal of block

Page 54: Surapong rsi 2009

SugammadexOrg 25969-Rocuronium complex formation

Gamma cyclodextrin

Org 25969 dose 8 mg/kg

Outside ring :hydrophilic

with negative charge

Inside ring :hydrophobic

***Inside cavity specific only to Rocuronium

Page 55: Surapong rsi 2009

หลับ

Page 56: Surapong rsi 2009

-50

-40

-30

-20

-10

0

10

20

Hea

rt r

ate

(%

fro

m b

ase

lin

e)

TIVA VIMA

Baseline BeforeIntubation

AfterIntubation

BeforeIncision

AfterIncision

BeforeExtubation

AfterExtubation

* *+

+

+ + +

+

+

Heart Rate

Page 57: Surapong rsi 2009

-50

-40

-30

-20

-10

0

10

20

MA

P (

% f

ro

m b

aseli

ne)

TIVA VIMA

Baseline BeforeIntubation

AfterIntubation

BeforeIncision

AfterIncision

BeforeExtubation

AfterExtubation

+

+ +

+

+ +

+

+

+

*

Blood Pressure

Page 58: Surapong rsi 2009

0

20

40

60

80

100

BIS

0

1

2

3

4

5

Ce P

ro

po

fo

l

(m

cg

/ml)

mean BIS mean Ce Propofol

Page 59: Surapong rsi 2009
Page 60: Surapong rsi 2009

Multi-compartmental pharmacokinetic models

Page 61: Surapong rsi 2009

Comp2

24 L

Comp1

4.3 L

Comp3

238 L

Multi-compartmental pharmacokinetic models

Page 62: Surapong rsi 2009

Propofol

Bolus 2 mg/kg

Page 63: Surapong rsi 2009

Propofol Bolus 2 mg/kg

3020100

Concentr

ation µ

g/m

l

10

9

8

7

6

5

4

3

2

1

0

Inf. R

ate

(ml/h

r) + D

ecr. T

ime

1000

900

800

700

600

500

400

300

200

100

0

3020100

Concentr

ation µ

g/m

l

10

9

8

7

6

5

4

3

2

1

0

Inf. R

ate

(ml/h

r) + D

ecr. T

ime

1000

900

800

700

600

500

400

300

200

100

0

3020100

Concentr

ation µ

g/m

l

10

9

8

7

6

5

4

3

2

1

0

Inf. R

ate

(ml/h

r) + D

ecr. T

ime

1000

900

800

700

600

500

400

300

200

100

0

3020100

Concentr

ation µ

g/m

l

10

9

8

7

6

5

4

3

2

1

0

Inf. R

ate

(ml/h

r) + D

ecr. T

ime

1000

900

800

700

600

500

400

300

200

100

0

Page 64: Surapong rsi 2009

IV Bolus

Personnel Controlled Infusion

• Drop counting

• Intermittent manual injection

Page 65: Surapong rsi 2009

IV line Trouble Shooting

• Occlusion

• Air in line

• Position

• Technique

Page 66: Surapong rsi 2009

Infusion Devices

Page 67: Surapong rsi 2009
Page 68: Surapong rsi 2009
Page 69: Surapong rsi 2009

Pre-load

Page 70: Surapong rsi 2009

Lorsomradee, et al: J Cardiothorac Vasc Anesth. 2007

Aug;21(5):492-6.

Leg Elevation

Page 71: Surapong rsi 2009

Response to

increased

cardiac load,

obtained by leg elevation

Page 72: Surapong rsi 2009

The End

Thank you

for your

attention